Clinical Trials List
Protocol NumberCVAY736Q12301
Active
2023-04-03 - 2028-04-03
Phase III
Not yet recruiting2
ICD-10D47.3
Essential (hemorrhagic) thrombocythemia
ICD-10D69.3
Immune thrombocytopenic purpura
ICD-10D69.41
Evans syndrome
ICD-10D69.42
Congenital and hereditary thrombocytopenia purpura
ICD-10D69.49
Other primary thrombocytopenia
ICD-9287.3
Primary thrombocytopenia
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- HSUAN JEN SHIH Division of Hematology & Oncology
- 洪玉馨 Division of Hematology & Oncology
- 王元欽 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
150 participants
